- Homepage | Fintepla HCP
Learn about FINTEPLA®, a treatment for seizures associated with Dravet syndrome and LGS, and get full Prescribing Information, including Boxed Warning
- FINTEPLA® (fenfluramine) | Official Patient Website
FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older It is not known if FINTEPLA is safe and effective in children less than 2 years of age
- Fintepla: Uses, Instructions, Side Effects, Warnings
Fintepla (fenfluramine) is used for the treatment of seizures associated with Dravet syndrome Includes Fintepla side effects, interactions and indications
- Results for UCBs Fintepla pave way for 3rd epileptic indication
UCB plans to file for regulatory approval of Fintepla to treat a third epileptic condition “as soon as possible,” the company
- UCB’s Fintepla led to nearly 50% seizure reduction in CDD . . .
UCB’s Fintepla (fenfluramine) has been associated with a nearly 50% reduction in countable motor seizure frequency (CMSF) in adult and paediatric patients with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) The company announced data from the Phase III GEMZ trial (NCT05064878) at the American Epilepsy Society (AES) meeting, which took place in Atlanta, US, from 5 to 9
- Fintepla: Uses, Side Effects, Dosage, Interactions, and More
Learn about uses, side effects, and more of Fintepla (fenfluramine), which is a prescription oral solution that treats seizures from certain types of epilepsy
- Fintepla (fenfluramine): Uses, Side Effects . . . - WebMD
Overview: Fintepla is used to treat certain types of seizures It may work by blocking certain signals that come from nerves and cause seizures Common side effects include weight loss, sleepiness
- UCB shares leading scientific research and advances at . . .
FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older FINTEPLA is available only through a restricted distribution program called the FINTEPLA REMS
|